Skip to content
HowShorted

Neurogene Inc. short interest in 2020

In 2020, Neurogene Inc.'s disclosed short interest ran from 4.27% of shares outstanding on 13 Mar 2020 to 7.15% on 31 Dec 2020, a change of +2.88 percentage points. The year's high was 8.75% on 30 Jun 2020 and its low 4.13% on 31 Mar 2020, averaging 6.13% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.24 days on 15 Oct 2020. Full history: Neurogene Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Neurogene Inc. in 2020

2020 in figures

Start of year
4.27% (13 Mar 2020)
End of year
7.15% (31 Dec 2020)
Change
+2.88 pp
High
8.75% (30 Jun 2020)
Low
4.13% (31 Mar 2020)
Average
6.13%
Highest days to cover
16.24 (15 Oct 2020)
SEC filings marked
8

Every report in 2020

Neurogene Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
13 Mar 20204.27%6.6410-K filed, results (8-K)
31 Mar 20204.13%4.65
15 Apr 20204.24%5.81
30 Apr 20205.22%8.54
15 May 20205.53%11.5310-Q filed, results (8-K)
29 May 20205.66%14.65
15 Jun 20206.06%8.22
30 Jun 20208.75%3.76
15 Jul 20207.98%4.20
31 Jul 20208.30%12.21
14 Aug 20207.74%13.7810-Q filed, results (8-K)
31 Aug 20206.55%14.58
15 Sep 20206.38%15.31
30 Sep 20206.13%12.54
15 Oct 20206.02%16.24
30 Oct 20206.10%15.98
13 Nov 20205.74%11.7210-Q filed, results (8-K)
30 Nov 20205.35%14.30
15 Dec 20205.23%13.80
31 Dec 20207.15%2.65

See also: Neurogene Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.